Aquaculture Vaccines Market is estimated to be US$ 946.5 million by 2032; Growing Prevalence of Fish Diseases in Aquaculture to Fuel Market Growth

Copyright © PROPHECY MARKET INSIGHTS 2022, All Rights Reserved
Aquaculture Vaccines Market: Industry,
Size, Share, Growth, Trends and Forecast,
2022–2032

Report Snippet
Copyright © PROPHECY MARKET INSIGHTS 2022, All Rights Reserved 2
Chapter 1 : Table of Contents
Chapter 3: Market Dynamics
Chapter 4: Global Aquaculture Vaccines Market, By
Route of Administrations
Chapter 2: Market Purview
Species
Type of Vaccines
Applications
Region
Chapter 9: Competitive Analysis Chapter 10:Company Profiles
Chapter 11:Research Methodology

Table of Contents

Table of Content
Sr. No. Content
1.0 Chapter 1
• Preface
• Research Objective and Assumption
• Abbreviation
2.0 Chapter 2
• Market Purview
• Report Description
• Market Definition and Scope
2.1 Executive Summary
• Market Snippet, By Route of Administrations
• Market Snippet, By Species
• Market Snippet, By Type of Vaccines
• Market Snippet, By Applications
• Market Snippet, By Region
• Opportunity Map Analysis
3.0 Chapter 3
Primary Source Secondary Source Prophecy Analysis

Table of Content
Sr. No. Content
• Drivers (D)
• Restrains (R)
• Opportunities
• Trends
• DR Impact Analysis
• PEST Analysis
• Porter’s Five Forces Analysis
• Opportunity Orbit
• Market Investment Feasibility Index
• Macroeconomic Factor Analysis
• World Aquaculture Production
4.0 Chapter 4
4.0.1 Global Aquaculture Vaccines Market Value (US$ Mn), By Route of Administrations
• Segment Overview
• Market Value and Forecast (US$ Mn), and Share (%) Analysis, 2022– 2032
• Y-o-Y Growth (%) Analysis, 2022 – 2032

Table of Content
Sr. No. Content
4.1 Spray vaccination
• Overview
• Market Value and Forecast (US$ Mn), and Y-o-Y Growth (%) Analysis, 2022– 2032
4.2 Oral vaccines
• Overview
4.3 Injection vaccines
• Overview
4.4 Immersion vaccines
• Overview
5.0 Chapter 5
5.0.1 Global Aquaculture Vaccines Market Value (US$ Mn), By Species

Table of Content
Sr. No. Content
5.1 Carps
• Overview
5.2 Salmon
• Overview
5.3 Sea Bass
• Overview
5.4 Sturgeon
• Overview
5.5 Trout
• Overview

Table of Content
Sr. No. Content
5.5 Other Species
• Overview
6.0 Chapter 6
6.0.1 Global Aquaculture Vaccines Market Value (US$ Mn), By Type of Vaccines
6.1 Inactivated vaccines
• Overview
6.2 Live vaccines
• Overview
6.3 Other Type of Vaccines
• Overview

Table of Content
Sr. No. Content
7.0 Chapter 7
7.0.1 Global Aquaculture Vaccines Market Value (US$ Mn), By Applications
7.1 Viral infection
• Overview
7.2 Bacterial infection
• Overview
7.3 Other Applications
• Overview

Table of Content
Sr. No. Content
8.0 Chapter 8
8.0.1 Global Aquaculture Vaccines Market Value (US$ Mn), By Region
• Overview
• Market Share (%) and BPS Analysis, By Region
8.1 North America
• Overview
• Market Value and Forecast (US$ Mn), 2022– 2032
• North America Aquaculture Vaccines Market, By Route of Administrations
• North America Aquaculture Vaccines Market, By Species
• North America Aquaculture Vaccines Market, By Type of Vaccines
• North America Aquaculture Vaccines Market, By Application
• North America Aquaculture Vaccines Market, By Country
8.1.1 U.S.

Table of Content
Sr. No. Content
8.1.2 Canada
8.2 Europe
• Overview
• Europe Aquaculture Vaccines Market, By Route of Administrations
• Europe Aquaculture Vaccines Market, By Species
• Europe Aquaculture Vaccines Market, By Type of Vaccines
• Europe Aquaculture Vaccines Market, By Application
• Europe Aquaculture Vaccines Market, By Country
8.2.1 Germany
8.2.2 UK
8.2.3 France

Table of Content
Sr. No. Content
8.2.4 Russia
8.2.5 Italy
8.2.6 Rest of Europe
8.3 Asia Pacific
• Overview
Market Value and Forecast (US$ Mn), 2022– 2032
Asia Pacific Aquaculture Vaccines Market, By Route of Administrations
Asia Pacific Aquaculture Vaccines Market, By Species
Asia Pacific Aquaculture Vaccines Market, By Type of Vaccines
Asia Pacific Aquaculture Vaccines Market, By Application
Asia Pacific Aquaculture Vaccines Market, By Country
8.3.1 China

Table of Content
Sr. No. Content
8.3.2 India
8.3.3 Japan
8.3.4 South Korea
8.3.5 Rest of Asia-Pacific
8.4 Latin America
• Overview
• Latin America Aquaculture Vaccines Market, By Route of Administrations
• Latin America Aquaculture Vaccines Market, By Species
• Latin America Aquaculture Vaccines Market, By Type of Vaccines
• Latin America Aquaculture Vaccines Market, By Application
• Latin America Aquaculture Vaccines Market, By Country

Table of Content
Sr. No. Content
8.4.1 Brazil
8.4.2 Mexico
8.4.3 Rest of Latin America
8.5 Middle East & Africa
• Overview
• Middle East & Africa Aquaculture Vaccines Market, By Species
• Middle East & Africa Aquaculture Vaccines Market, By Route of Administrations
• Middle East & Africa Aquaculture Vaccines Market, By Type of Vaccines
• Middle East & Africa Aquaculture Vaccines Market, By Application
• Middle East & Africa Aquaculture Vaccines Market, By Country
8.5.1 GCC

Table of Content
Sr. No. Content
8.5.2 Israel
8.5.3 South Africa
8.5.4 Rest of Middle East & Africa
9.0 Chapter 9
9.1 Competitive Landscape
• Competitive Overview
• Heat Map Analysis
• Market Presence and Specificity Analysis
10.0 Chapter 10
• Company Profiles
10.1 HIPRA
• Company Overview
• Product Portfolio

Table of Content
Sr. No. Content
• Key Highlights
• Financial Overview
10.2 Virbac
• Key Highlights
10.3 Zoetis Inc.
• Key Highlights
10.4 Tecnovax
• Key Highlights

Table of Content
Sr. No. Content
10.5 Merck& Co.
• Key Highlights
10.6 Veterquimica S.A.
• Key Highlights
10.7 Elanco
• Key Highlights

Table of Content
Sr. No. Content
10.8 KoVax Ltd
• Key Highlights
10.9 Nisseiken Co.,Ltd,
• Key Highlights
10.10 Pfizer
• Key Highlights
11.0 Chapter 14
• Research Methodology
• About Us
*The content/data is provided for illustration purpose only and is subject to change in the final version of the report

Notes
 The segmentation provided on the segmentation page is the actual/proposed segmentation for the target market
 Content and statistical data /values offered in the sample is primarily to provide an understanding of what we offer in terms of style,
content, and structure and may not necessarily to be related to actual for the requested market
 Market value/revenue for the target market will be provided in the final version of the report
 The company names mentioned are those that are to be actually profiled in the final report
 The trailing slides that contain dummy data/hidden content for the target market is provided to gain a better understanding of our
competence, as well as a clearer view of how and what we offer in our report.
 The number of slides/pages provided for segment and region will be followed in a similar manner for remaining segments of the
target market.
 The values provided in the table’s, graphs, and figure’s are for illustration purpose only.
Points to Remember
Source: Prophecy Market Insights

Preface
Chapter 01

 Scope of The Report: This report will help manufacturers, distributors, and retailers to realize and understand the market drivers, restraints, and
opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue etc. The report also serves to
offer insights for investors to understand the specific industry, market, and make strategic decisions. In addition, it will serve to gain insights
regarding the various players in the market, their financials, recent developments, and strategies adopted and employed in terms of expansion,
mergers and acquisitions, collaborations, strategic agreements and contracts etc., as well as Application offerings.
 Analytical framework involves pest analysis and porters of the target market
 Sourcing of the data throughout the report includes : extensive primary and secondary research data analysis
 Global Aquaculture Vaccines market is segmented on the basis By Route of Administrations, Species, Type of Vaccines, Applications, and Region.
 By Route of Administrations (Spray vaccination, Oral vaccines, Injection vaccines, Immersion vaccines)
 By Species (Fixed Mounting, Carps, Salmon, Surgeon, Trout, and Other Species)
 By Type of Vaccines (Inactivated vaccines, Live vaccines, Other Type of Vaccines)
 By Applications (Viral infection, Bacterial infection, Other Applications)
 By Region: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
21
Market Definition and Scope
Preface

Research Objective and Assumption
22

Research Objectives and Assumptions
Research Objectives
Assumptions

Abbreviations
Abbreviation and Full Application
Abbreviation Full Form
Mn Million
Bn Billion
US$ US Dollar
CAGR Compounded Annual Growth Rate
Y-o-Y Year on Year

Market Preview
Chapter 02
2
5

26
Market Segmentation
Global Aquaculture Vaccines Market
By Route of Administrations
By Species
 Carps
 Salmon
 Sea Bass
 Sturgeon
 Trout
 Other Species
(Turbot, Sea bream,
tilapia)
By Region
 Spray vaccination
 Oral vaccines
 Injection vaccines
 Immersion vaccines
 Inactivated vaccines,
 Live vaccines
 Other Type of
Vaccines (Activated
Vaccine and DNA
vaccine)
By Type of Vaccines
By Applications
 Viral infection
 Bacterial infection
 Other
Applications(Parasitic
infection, Fungal
infection, Combined
Bacterial)
 North America
 Europe
 Asia Pacific
 Latin America
 Middle East & Africa

Executive Summary (1/4)
27
Table 2.1: Global Aquaculture Vaccines Market Overview
Parameters 2022 (E) 2032 (F)
Global Aquaculture Vaccines Market Value (US$ Mn) 381.4Mn 946.5Mn
By Route of Administrations Segment with Largest Value (US$
Mn)
Spray vaccination: XXX.X Spray vaccination : XXX.X
By Route of Administrations Segment with Highest CAGR (%)-
2022-2032
Spray vaccination: CAGR- XX.X
By Species Segment with Largest Value (US$ Mn) Carps: XXX.X Carps: XXX.X
By Species Segment with Highest CAGR (%)-2022-2032 Carps: CAGR- XX.X
To be continued…

28
Table 2.2: Global Aquaculture Vaccines Market Overview
Key Market Players:
HIPRA, Virbac, Zoetis Inc., Tecnovax, Merck& Co., Inc., and
Veterquimica S.A., Elanco, KoVax Ltd, Nisseiken Co.,Ltd, Pfizer,
By Type of Vaccines Segment with Largest Value (US$ Mn) Inactivated vaccines: XXX.X Inactivated vaccines: XXX.X
By Type of Vaccines Segment with Highest CAGR (%)-2022-2032 Inactivated vaccines :XX.X
By Applications Segment with Largest Value (US$ Mn) Viral infection: XXX.X Viral infection: XXX.X
By Applications Segment with Highest CAGR (%)-2022-2032 Viral infection :CAGR - XX.X

Analysis and Outcomes
Figure 2.1: Global Aquaculture Vaccines Market Value Share (%), By Route of
Administrations – 2022 (E)
Figure 2.2: Global Aquaculture Vaccines Market Value Share (%), By Species –
2022 (E)
37%
Spray vaccination
Oral vaccines
Injection vaccines
Immersion vaccines
Carps
Salmon
Sea Bass
Sturgeon
Trout
Other Species
XX.X%
 The injected segment held the largest share of 36.73% in 2020.
Apex-IHN by Elanco is the first DNA vaccine licensed in Canada
for protection against IHNV in healthy salmonid fishes. Alpha
Ject lineup by Zoetis is injectable Aquaculture Vaccines for
protection against various diseases, including furunculosis,
vibriosis, cold-water vibriosis, winter sore, IPN, and Infectious
Salmon Anemia (ISA).
 The oral segment is expected to expand at the highest CAGR of
8.7% during the forecast period. Oral vaccination has several
advantages over other routes of administration.

XX.X%
XX.X%
Inactivated vaccines
Live vaccines
Other Type of Vaccines
Figure 2.3: Global Aquaculture Vaccines Market Value Share (%), By Type of
Vaccines – 2022 (E)
Figure 2.4: Global Aquaculture Vaccines Market Value Share (%), By
Applications– 2022 (E)
Viral infection
Bacterial infection
Other Applications
43.94%
34.89%
North America Europe
Asia Pacific Latin America
Figure 2.5: Global Aquaculture Vaccines Market Value Share (%), By Region –
2022 (E)
25.0%
Analysis and Outcomes
 Inactivated vaccines held the largest share of 34.89% in
2020. Inactivated bacterial and viral vaccines are
manufactured by the fermentation of the disease-causing
pathogens in large quantities. Inactivating agents such as
formalin are then introduced to kill all the microorganisms.
 The bacterial segment held the largest share of 43.94% in
2020. As per Aquatic Animal Health Research by the USDA,
bacterial species of more than 20 genera have been
identified as causative agents behind Aquatic diseases.

Opportunity Map Analysis
XXX.X
XXX.X
XXX.X
120.0
320.0
520.0
720.0
920.0
1120.0
1320.0
1520.0
1720.0
Likely Conservative Optimistic
Opportunity Map Analysis, by Market Value (US$ Mn) and
CAGR (%) Analysis and Outcome
CAGR
XX.X%
XX.X%
XX.X%
Likely
Conservative
Optimistic
Market Value (US$ Mn) - 2032

Market Dynamics
Chapter 03

Market Dynamics
Driver
Surging prevalence of bacterial and viral infections
Increasing aquaculture production across the globe
Development and launch of new aquaculture vaccines
Restrain
Stringent regulatory policies for vaccine approval
Complex vaccine development procedures
Opportunity
Research and development

Drivers (1/3)
 Global seafood provides nearly 20% of all animal protein in diets, and aquaculture is, in the
face of weakening trends, the fastest growing food sector globally. Currently rises in
production have largely been achieved through intensification of existing farming systems,
resulting in higher risks of disease outbreaks Such factor support the target market growth.
 For instance, According to Aquaculture Research & Development journal, from 2014 to 2018,
approximately 219 cases of infectious diseases in the fresh aquaculture sector were
registered. Among these, 74.88% were parasitic, 12.80% were bacterial, 1.83% were viral,
and 10.50% cases were a mix of parasitic and bacterial diseases.
Surging prevalence of bacterial and viral infections

Drivers (2/3)
 Increasing demand of sea food is propelling the growth of aquaculture production.
 For instance According to FAO org U.S. Global fish production* peaked at about 171
million tonnes in 2016, with aquaculture representing 47 percent of the total and 53
percent, if non-food uses (including reduction to fishmeal and fish oil) are excluded.
Increasing aquaculture production across the globe

Drivers (3/3)
 Vaccination plays an important role in large-scale commercial fish farming and has been a
key reason for the success of Aquaculture therefore the advancement in vaccine is needed to
improve the quality and quantity . That’s a reason many company are continuously focusing
of the research and development of product.
 For instance, during its Q3 earnings release, Zoetis reported a 13% higher revenue compared
to the third quarter of the previous year. The performance was driven by the newly launched
companion animal parasiticide product as well as Zoetis’ key dermatology portfolio.
Development and launch of new aquaculture vaccines

Restraint (1/2)
Stringent regulatory policies for vaccine approval

Restraint (2/2)
Complex vaccine development procedures

Opportunity
Research and development

Trend
 Current advances in vaccines and vaccinology offer valuable opportunities to discover new
vaccine candidates to combat fish pathogens, including mycotic and parasitic agents, for
which vaccines are still lacking.
Improving existing vaccines for rendering protection from various types of infectious diseases

SWOT Analysis
S W
O T
Strengths
Opportunities
Weakness
Threats

Drivers and Restraints Impact Analysis
Low High
Low
High
Impact on Market Value
Likely
Growth
Impact
on
Market
Growth
Rate
D1
D2
D3
R1
R2
Drivers
Restraints
Complex vaccine
development procedures
Development and launch of
new aquaculture vaccines
Increasing aquaculture
production across the globe
Surging prevalence of
bacterial and viral infections
Stringent regulatory policies
for vaccine approval
Sample for Illustration Purpose

Opportunity Orbit
Sample for Illustration Purpose

PEST Analysis (1/4)
Political Analysis
POLITICAL
SOCIAL
ECONOMICAL
TECHNOLOGICAL

PEST Analysis (2/4)
Economical Analysis
POLITICAL
SOCIAL
ECONOMICAL
TECHNOLOGICAL

PEST Analysis (3/4)
Social Analysis
POLITICAL
SOCIAL
ECONOMICAL
TECHNOLOGICAL

PEST Analysis (4/4)
Technological Analysis
POLITICAL
SOCIAL
ECONOMICAL
TECHNOLOGICAL

PORTER’S Five Forces Analysis
Threat of New Entrants
Rivalry
Buyer Power
Supplier Power Threat of Substitutes

Global Aquaculture Production Analysis
0
20
40
60
80
100
120
140
160
180
2000 2005 2010 2016
Years
Millions
Tones

Global Aquaculture Vaccines Market, By
Route of Administrations
Chapter 04

Table 4.1: Global Aquaculture Vaccines Market Value and Forecast (US$ Mn), By Route of Administrations - 2021–
2032
Global Aquaculture Vaccines Market, By Route of Administrations
Route of
Administrations
2021 A 2022E 2023 F 2024F 2025 F 2026 F 2027 F 2028 F 2029 F 2030 F 2031 F 2032 F
CAGR
(2021
–32)
Spray
vaccination
XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Oral vaccines XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Injection
vaccines
Immersion
vaccines
Total XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X

Figure 4.1 : Global Aquaculture Vaccines Market Value and Forecast (US$ Mn),
and Y-o-Y Growth (%), By Route of Administrations - 2022-2032
 The Global Aquaculture Vaccines market by By Route of
Administrations segment was valued US$ XXX.X Mn in
2022and is expected to reach US$ XXX.X Mn in 2032, and
register a CAGR of XX.X% over the forecast period
 The first six year (2022-2027) cumulative value is projected
to be US$ XXX.X Mn, as compared to relatively higher
cumulative value of US$ XXX.X Mn for the last six year
(2024-2032) of the forecast period
 The Spray vaccination segment accounted for value share
XX.X in 2022 and is expected to increase to XX.X% in 2032
Analysis and Outcome
X.XX Projected growth between 2022 and 2032 Source: Prophecy Market Insights
0.0%
0.1%
0.2%
0.3%
0.4%
0.5%
0.6%
0.7%
0.8%
0.9%
1.0%
1.1%
1.2%
1.3%
1.4%
1.5%
1.6%
1.7%
1.8%
1.9%
2.0%
2.1%
2.2%
2.3%
2.4%
2.5%
2.6%
2.7%
2.8%
2.9%
3.0%
3.1%
3.2%
3.3%
3.4%
3.5%
3.6%
3.7%
3.8%
3.9%
4.0%
4.1%
4.2%
4.3%
4.4%
4.5%
4.6%
4.7%
4.8%
4.9%
5.0%
5.1%
5.2%
5.3%
5.4%
5.5%
5.6%
5.7%
5.8%
5.9%
6.0%
6.1%
6.2%
6.3%
6.4%
6.5%
6.6%
6.7%
6.8%
6.9%
7.0%
7.1%
7.2%
7.3%
7.4%
7.5%
7.6%
7.7%
7.8%
7.9%
8.0%
8.1%
8.2%
8.3%
8.4%
8.5%
8.6%
8.7%
-
500.0
1,000.0
1,500.0
2,000.0
2,500.0
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Value Y-O-Y

Spray vaccination
Figure 4.2 : Global Aquaculture Vaccines Market Value and Forecast (US$ Mn),
and Y-o-Y Growth), Spray vaccination , 2022-2032
 The Global Aquaculture Vaccines market by Spray
vaccination, was valued US$ XXX.X Mn in 2022and is
expected to reach US$ XXX.X Mn in 2032, and register a
CAGR of XX.X% over the forecast period
0.0%
0.1%
0.2%
0.3%
0.4%
0.5%
0.6%
0.7%
0.8%
0.9%
1.0%
1.1%
1.2%
1.3%
1.4%
1.5%
1.6%
1.7%
1.8%
1.9%
2.0%
2.1%
2.2%
2.3%
2.4%
2.5%
2.6%
2.7%
2.8%
2.9%
3.0%
3.1%
3.2%
3.3%
3.4%
3.5%
3.6%
3.7%
3.8%
3.9%
4.0%
4.1%
4.2%
4.3%
4.4%
4.5%
4.6%
4.7%
4.8%
4.9%
5.0%
5.1%
5.2%
5.3%
5.4%
5.5%
5.6%
5.7%
5.8%
5.9%
6.0%
6.1%
6.2%
6.3%
6.4%
6.5%
6.6%
6.7%
6.8%
6.9%
7.0%
7.1%
7.2%
7.3%
7.4%
7.5%
7.6%
7.7%
7.8%
7.9%
8.0%
8.1%
8.2%
8.3%
8.4%
8.5%
8.6%
8.7%
-
500.0
1,000.0
1,500.0
2,000.0
2,500.0
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Value Y-O-Y

Oral vaccines
Figure 4.3: Global Aquaculture Vaccines Market Value and Forecast (US$ Mn),
and Y-o-Y Growth (%), Oral vaccines, 2022-2032
 The Global Aquaculture Vaccines market by Oral vaccines,
was valued US$ XXX.X Mn in 2022and is expected to reach
US$ XXX.X Mn in 2032, and register a CAGR of XX.X% over
the forecast period
0.0%
0.1%
0.2%
0.3%
0.4%
0.5%
0.6%
0.7%
0.8%
0.9%
1.0%
1.1%
1.2%
1.3%
1.4%
1.5%
1.6%
1.7%
1.8%
1.9%
2.0%
2.1%
2.2%
2.3%
2.4%
2.5%
2.6%
2.7%
2.8%
2.9%
3.0%
3.1%
3.2%
3.3%
3.4%
3.5%
3.6%
3.7%
3.8%
3.9%
4.0%
4.1%
4.2%
4.3%
4.4%
4.5%
4.6%
4.7%
4.8%
4.9%
5.0%
5.1%
5.2%
5.3%
5.4%
5.5%
5.6%
5.7%
5.8%
5.9%
6.0%
6.1%
6.2%
6.3%
6.4%
6.5%
6.6%
6.7%
6.8%
6.9%
7.0%
7.1%
7.2%
7.3%
7.4%
7.5%
7.6%
7.7%
7.8%
7.9%
8.0%
8.1%
8.2%
8.3%
8.4%
8.5%
8.6%
8.7%
-
500.0
1,000.0
1,500.0
2,000.0
2,500.0
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Value Y-O-Y

Injection vaccines
and Y-o-Y Growth (%), Injection vaccines, 2022-2032
 The Global Aquaculture Vaccines market by Injection
vaccines, was valued US$ XXX.X Mn in 2022and is expected
to reach US$ XXX.X Mn in 2032, and register a CAGR of
XX.X% over the forecast period
0.0%
0.1%
0.2%
0.3%
0.4%
0.5%
0.6%
0.7%
0.8%
0.9%
1.0%
1.1%
1.2%
1.3%
1.4%
1.5%
1.6%
1.7%
1.8%
1.9%
2.0%
2.1%
2.2%
2.3%
2.4%
2.5%
2.6%
2.7%
2.8%
2.9%
3.0%
3.1%
3.2%
3.3%
3.4%
3.5%
3.6%
3.7%
3.8%
3.9%
4.0%
4.1%
4.2%
4.3%
4.4%
4.5%
4.6%
4.7%
4.8%
4.9%
5.0%
5.1%
5.2%
5.3%
5.4%
5.5%
5.6%
5.7%
5.8%
5.9%
6.0%
6.1%
6.2%
6.3%
6.4%
6.5%
6.6%
6.7%
6.8%
6.9%
7.0%
7.1%
7.2%
7.3%
7.4%
7.5%
7.6%
7.7%
7.8%
7.9%
8.0%
8.1%
8.2%
8.3%
8.4%
8.5%
8.6%
8.7%
-
500.0
1,000.0
1,500.0
2,000.0
2,500.0
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Value Y-O-Y

Immersion vaccines
and Y-o-Y Growth (%), Immersion vaccines, 2022-2032
 The Global Aquaculture Vaccines market by Immersion
vaccines, was valued US$ XXX.X Mn in 2022and is expected
to reach US$ XXX.X Mn in 2032, and register a CAGR of
XX.X% over the forecast period
0.0%
0.1%
0.2%
0.3%
0.4%
0.5%
0.6%
0.7%
0.8%
0.9%
1.0%
1.1%
1.2%
1.3%
1.4%
1.5%
1.6%
1.7%
1.8%
1.9%
2.0%
2.1%
2.2%
2.3%
2.4%
2.5%
2.6%
2.7%
2.8%
2.9%
3.0%
3.1%
3.2%
3.3%
3.4%
3.5%
3.6%
3.7%
3.8%
3.9%
4.0%
4.1%
4.2%
4.3%
4.4%
4.5%
4.6%
4.7%
4.8%
4.9%
5.0%
5.1%
5.2%
5.3%
5.4%
5.5%
5.6%
5.7%
5.8%
5.9%
6.0%
6.1%
6.2%
6.3%
6.4%
6.5%
6.6%
6.7%
6.8%
6.9%
7.0%
7.1%
7.2%
7.3%
7.4%
7.5%
7.6%
7.7%
7.8%
7.9%
8.0%
8.1%
8.2%
8.3%
8.4%
8.5%
8.6%
8.7%
-
500.0
1,000.0
1,500.0
2,000.0
2,500.0
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Value Y-O-Y

Global Aquaculture Vaccines Market,By
Region
Chapter 08

Region Overview
Figure 8.1: Global Aquaculture Vaccines Market Value Share (%) By Region -2022
XX.X%
XX.X%
XX.X%
X.X%
XX.X%

Market Share (%) and BPS Analysis, By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Market
Share
in 2022
Market
Share
in 2032
Change
in BPS

Table 8.1: Global Aquaculture Vaccines Market Value and Forecast (US$ Mn), By Region - 2021–2032
Global Aquaculture Vaccines Market, By Region
Region 2021 A 2022E 2023 F 2024F 2025 F 2026 F 2027 F 2028 F 2029 F 2030 F 2031 F 2032 F
CAGR
(2021–
32)
North America XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Europe XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Asia Pacific XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Latin America XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
MEA XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X

North America
XX.X%
Market Share (%) - 2018
North America
Rest of the
World

U.S. is expected to dominate with XX.X% of market share in the year XXXX
North America
 This statistic shows the value of the
aquaculture production in the United
States from 2010 to 2019. In 2019, the
production value of U.S. aquaculture
industry came to just under 1.5 billion
U.S. dollars.
Aquaculture production value in the United States from 2010 to 2019 (in million U.S. dollars)

North America
Figure 8.2: North America Market Value and Forecast (US$ Mn), and Y-
o-Y Growth (%), 2022– 2032
 The North America was valued at US$ XXX.X Mn in 2022and
is expected to reach US$ XXX.X Mn in 2032, and register a
CAGR of XX.X% over the forecast period.
 North America Aquaculture Vaccines market value Y-o-Y
growth rate is expected to remain steady over the forecast
period.
 The U.S. accounted for value share XX.X% in 2022 and is
expected to increase to XX.X % in 2032.
X.XX Projected growth between 2022 and 2032
0.0%
0.1%
0.2%
0.3%
0.4%
0.5%
0.6%
0.7%
0.8%
0.9%
1.0%
1.1%
1.2%
1.3%
1.4%
1.5%
1.6%
1.7%
1.8%
1.9%
2.0%
2.1%
2.2%
2.3%
2.4%
2.5%
2.6%
2.7%
2.8%
2.9%
3.0%
3.1%
3.2%
3.3%
3.4%
3.5%
3.6%
3.7%
3.8%
3.9%
4.0%
4.1%
4.2%
4.3%
4.4%
4.5%
4.6%
4.7%
4.8%
4.9%
5.0%
5.1%
5.2%
5.3%
5.4%
5.5%
5.6%
5.7%
5.8%
5.9%
6.0%
6.1%
6.2%
6.3%
6.4%
6.5%
6.6%
6.7%
6.8%
6.9%
7.0%
7.1%
7.2%
7.3%
7.4%
7.5%
7.6%
7.7%
7.8%
7.9%
8.0%
8.1%
8.2%
8.3%
8.4%
8.5%
8.6%
8.7%
-
500.0
1,000.0
1,500.0
2,000.0
2,500.0
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Value Y-O-Y

Table 8.2: Global Aquaculture Vaccines Market Value and Forecast (US$ Mn), By Route of Administrations - 2021–
2032
Route of
Administrations
2021 A 2022E 2023 F 2024F 2025 F 2026 F 2027 F 2028 F 2029 F 2030 F 2031 F 2032 F
CAGR
(2021
–32)
Spray
vaccination
Oral vaccines XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Injection
vaccines
Immersion
vaccines

Table 8.3: Global Aquaculture Vaccines Market Value and Forecast (US$ Mn), By Species -2021–2032
Global Aquaculture Vaccines Market, By Species
By Species 2021 A 2022E 2023 F 2024F 2025 F 2026 F 2027 F 2028 F 2029 F 2030 F 2031 F 2032 F
CAGR
(2021
–32)
Carps XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Salmon XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Sea Bass XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Sturgeon XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Trout XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Other Species XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X

Table 8.4: Global Aquaculture Vaccines Market Value and Forecast (US$ Mn), By Type of Vaccines- 2021–2032
Global Aquaculture Vaccines Market, By Type of Vaccines
By Type of
Vaccines
2021 A 2022E 2023 F 2024F 2025 F 2026 F 2027 F 2028 F 2029 F 2030 F 2031 F 2032 F
CAGR
(2021
–32)
Inactivated
vaccines
Live vaccines XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Other Type of
Vaccines

Table 8.5: Global Aquaculture Vaccines Market Value and Forecast (US$ Mn), By Applications
- 2021–2032
Global Aquaculture Vaccines Market, By Applications
By Applications 2021 A 2022E 2023 F 2024F 2025 F 2026 F 2027 F 2028 F 2029 F 2030 F 2031 F 2032 F
CAGR
(2021
–32)
Viral infection,, XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Bacterial
infection
Other
Applications XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X

North America
Table 6.6: North America Market Value and Forecast (US$ Mn) By Country, 2021 – 2032
XXX.X
XX.X
XX.X
US Canada
Figure 7.3: North America Market Value (US$ Mn) Overview, By Country 2022and 2032
Country 2021 A 2022E 2023 F 2024F 2025 F 2026 F 2027 F 2028 F 2029 F 2030 F 2031 F 2032 F
CAGR
(2021–
32)
U.S. XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X
Canada XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XXX.X XX.X

Company Profiles
Chapter 09

Evonik Industries AG (1/7) (For Sample Purpose*)
Company Overview
 Evonik Industries AG., is the second largest chemical company in
Germany and has become the second largest specialty chemicals
company in the world.
 The primary business of company is manufacturing specialty
chemicals. The company also makes active oxygen for
agriculture, additives for diesel application, car & transportation
coatings, active oxygen for mining, components for oil and gas
applications, and others.
Business Overview
 Specialty Additives
 Nutrition & Care
 Smart Materials
 Performance Materials
 Technology & Infrastructure
Company Division
Established 2007
Key Management Christian Kullman (CEO)
Private/Public -
Headquarter Essen, Germany
Headcount 33,106 (2020)
Geographic Presence
Asia-Pacific, North America,
Europe
Total Value (USD$ Mn), 2022 19,480.43Mn
Value Growth (%) Over Previous
Year
22.8%
Key Business Segments
Chemicals, Energy, Real estate,
inorganic materials, coatings and
additives, health & nutrition, and
performance polymer products.
Website www.evonik.com
Source: Company Annual Reports and Website

72
Key Highlights
Evonik Industries AG (2/7)
2017 2022
Evonik Industries AG joint
venture Cyplus and Idesa
opened new sodium cyanide
production plant in
Coatzacoalcos, Veracruz,
Mexico with capacity of
40,000 metric tons and uses
hydrocyanic acid and cyanide
technologies.
Evonik is embarking on next
phase of its strategic
transformation by executing
targeted and massive
investments in green growth
and making sustainability the
company’s central innovation
driver.

Company Financial (USD Mn) Overview, by Year
 Evonik Industries AG has reported value USD$ 12,944.13 Mn, in
the year of 2020; which has increased up to 19,480.43Mn in year
2022.
 Recent outbreak of COVID-19, weakening economic conditions
which led to reduction in investment activities and increase in
cost of raw materials and energy has led to reduction in profit in
2020.
 Evonik has established itself among the leaders in chemicals
sector in renowned sustainability ratings & indices like
Sustainanalytics, MSCI, ISS-oekom, CDP, and EcoVadis. The
company represented range of SRI funds & sustainability
oriented index families. This good positioning shows that capital
market rewards Evonik’s commitment to sustainability.
12,944.13
15,868.47
19,480.43
0.00
5,000.00
10,000.00
15,000.00
20,000.00
25,000.00
2020 2021 2022
1 EURO = 1.05 USD

Company Financial (USD$ Mn) Overview, by Year
 Evonik Industries AG has reported value USD$ 15,300Mn, in the
year of 2017; which was decreased up to 13,908.65Mn in year
2019.
 The development of considerably lower global economic
conditions which was poor. The company estimated the global
economy as a whole grew by around 2.6% in 2019.
 The acquisition of specialty additives business of Air Products and
Chemicals Inc., Allentown and M. Huber Corporation, Atlanta
strengthen the Evonik’s leading position on attractive growth
market for specialty additives, smart materials, animal nutrition,
and health care. .
 Net income failed due to higher expenses in connection with
acquisition held in 2017.
15,300.99
15,943.00
13,908.65
12,500.00
13,000.00
13,500.00
14,000.00
14,500.00
15,000.00
15,500.00
16,000.00
16,500.00
2017 2018 2019
1 EURO = 1.05 USD

Company R&D expenses (USD$ Mn) Overview, by
Year
 Evonik Industries AG, has R&D locations worldwide and around
2,700 R&D employees. R&D expenses are totaled around
487.30mn in 2022.
 In 2022, Evonik has forward many research projects with which it
will make a contribution to transition to sustainability and more
efficient of resources.
 Currently Evonik’s operational chemicals division accounted for
around 85% of its R&D expenses while Creavis accounted for
15%.
 Value and quality of patent portfolio has increased steadily I
recent years and 256 new patent applications were submitted in
2022, and the company has around 24,000 patents and pending
patents.
462.93
453.40
458.69
491.53
487.30
430.00
440.00
450.00
460.00
470.00
480.00
490.00
500.00
2018 2019 2020 2021 2022
1 EURO = 1.05 USD

Value Share (%) Overview, by Division 2022
 Largest share accounted for smart materials of around 26%.
 Specialty Additives sector holds around 23% of share value.
 Nutrition & Care holds around 23% of share value.
 Performance materials holds around 205 of share value while
Technology & infrastructure holds around 8% of share value.
8.00%
20.00%
26.00%
23.00%
23.00%
Technology &
Infrastructure
Performance Materials
Smart Materials
Specilaty Additives
Nutrition & Care

Value Share (%) Overview, by Geography 2022
 Largest share accounted for Europe, Middle East and African
region with 51%.
 Asia-Pacific account for around 20% of share value.
 North America holds around 24% of share value, while Centrla &
South America holds around 5% of share value.
 Evonik has major production and R&D facilities in Greater China
at ten locations including Changchun, Jilin, Liaoyang, Nanning,
Nanjing, Nanping, Rizhao, Shanghai, Taiwan and Qingdao.
 Evonik has production and R&D facilities at six locations in Japan
which includes, Aboshi, Ako, Isehara, Kawasaki, Tsukuba, and
Yokkaichi.
 Major production facilities of Evonik are in Greater China and
secondly in Japan.
20.00%
5.00%
24.00%
51.00%
Asia Pacific
Central & South
America
North America
Europe, Middle East
and Africa

Business Strategies Overview
 The clear specialty chemicals character and markets with above average growth & margins
characterize Evonik’s portfolio management and investments. Starting from leading market
positions, Evonik continuously expand its growth engines in specialty additives, smart
materials, health & care and animal nutrition.
 Further, Evonik is involved in R&D, which work closely with customers and external partners.
Broad Portfolio and
Customer Focused
Innovation
 Evonik has involved in cost management and is expected to deliver USD$266.52 million
savings in 2023. As the company has decided to use less of consultants, has reduced fair &
event participation and also reduced sponsoring.
Cost Management

Business Strategies Overview
 Awards and recognition, for exceeding and fulfilling expectations of consumers, employees,
suppliers, shareholders, & communities are the business strategies of company.
 In July 2022, Evonik recognized by the Ringier Technology Awards for personal care for
fourth consecutive year and most prestigious awards in China’s beauty industries.
 Evonik received two industrial awards for its “SPHINOX Lift” short chain ceramide and
“TEGO Sterol 7-DHC V” vegetal sourced cholesterol derivative.
 The double award winning by Evonik has strenghthened its leading position as an innovative
specialty chemicals player with strong sustainability principles.
Brand Recognition

Research Methodology
Chapter 10
80

Secondary Research –
- Annual Reports
- Trade Publications
- Research Studies
- Press Releases
In-house Data Analysis –
Data Analysis by using
various tools and
statistical methods
Primary Research -
Data Collection
and Interpretation
Market Insights
Validation and
Final Conclusions

Global Market Size
Market/Revenue share of each key player in each
Deployment segment
Market/Revenue share of each key player in the
global market
Bottom-up Approach –
Collection of market related data and information
from primary and secondary sources, and data
analysis.
Primary Sources:
 Demand Side Key Opinion Leaders
 Supply Side Key Opinion Leaders
Secondary Sources:
 Annual Reports
 Financial Reports and Presentations
 Press Releases
 Research Journals
 Paid Data Sources
Market/Revenue share split by each market segment
such as by Deployment organization size/Application
sector/end user
Market/Revenue share split by each region and
Region in the global market
Top-down Approach –
Market size and analysis validation through primary
and secondary research participants and key opinion
leaders.
Primary Sources:
 Demand Side Key Opinion Leaders
 Supply Side Key Opinion Leaders
Secondary Sources:
 Annual Reports
 Financial Reports and Presentations
 Press Releases
 Research Journals
 Paid Data Sources

Definition and Scope – Prophecy Market Insights provide the market definition to
understand the target Deployment/service and provide the market scope to
understand the report coverage after thoroughly understanding of target market
and market specific requirements.
Primary Research – We formulates a detailed discussion guide to perform primary
research. In primary research collection of data is performed through telephonic
interview, E-mail questionnaire’s, and in-depth discussion with industry experts,
manufacturers, suppliers, distributors, and Applications. The primary research
participant includes but not limited to CEO’s, Managers, Directors, VP’s, Suppliers,
CSO’s, and etc.
Secondary Research – Our research analyst performs in-depth secondary research
and extensive data mining to collect market related information through various
authentic data sources such as Annual Reports, Trade Publications, Magazines,
Research Publications, Company Press Release, and some paid data sources.
In-house Data Analysis – After extensive data mining, we perform in-house market
analysis by using various data tools, statistical methods, and data analysis tools to
arrive on a conclusion and reduce the margin of error. We provide our overviews
and market forecast for the target market after thoroughly understanding and
analyzing of collected data, historic market trends, and research outputs.
Report Delivery – Prophecy Market Insights provide report in required electronic
format (preferably in PDF format), as PDF format is easy to read and present.

About Us
84

About Us
85
Who we are:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and
tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target
business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and
transform their business.
Prophecy’s expertize area covers Deployments, services, latest trends, developments, market growth factors, and challenges along with
market forecast in various business areas such as Healthcare, Pharmaceutical, Biotechnology, Information Technology (IT),Viral infection,
Farm (SMEs), Chemical, Agriculture, Food and Beverage, Energy, and Oil and Gas. We also offer various other services such as, data
mining, information management, and revenue enhancement suggestions.
We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never
return down from any challenge. At prophecy we cater to industries, individuals, and organizations across the globe and deliver our
offerings in the shortest possible turnaround time.
Our well defined approach ensures our clients will receive unique competitive advantage, and secure and long lasting results.
“WE BELIEVE IN LONG–TERM BUSINESS RELATIONS FOR GROWTH AND SUCCESS”

About Us
Copyright © PROPHECY 2022, All Rights Reserved 86
Disclaimer
 The material is based on sources which we believe are reliable, but no warranty, either expressed or implied, is provided in relation to
the accuracy or completeness of the information. The views expressed are our best judgment as of the date of issue and are subject to
change without notice. Prophecy Market Insights takes no responsibility for decisions made on the basis of these opinions.
 Any redistribution of this information is strictly prohibited. Copyright © 2022 Prophecy Market Insights pvt. Ltd , all rights reserved.
Legal and Copyright Notices
 While the editors endeavor to ensure the accuracy of all information and data contained in this Market Research Report, neither they
nor Prophecy Market Insights Pvt. Ltd. accept responsibility for any loss or damage (whether direct or indirect) whatsoever to the
customer or any third party resulting or arising there from.
 All rights reserved. No part of this publication may be reproduced or used in any form or by any means graphic, electronic or
mechanical, including photocopying, recording, taping, or information storage and retrieval systems without permission of the
publisher.
Disclaimer:
Prophecy market Insights Pvt. Ltd attempts to ensure that the information provided in our market research reports is as accurate and
complete as possible, the quantity of detailed information used and the fact that some of the information (which cannot always be verified
or validated) is supplied by third parties and sources not controlled by prophecy market Insights Pvt. ltd means that we cannot always
guarantee the accuracy, completeness or originality of the information in some reports, and we are therefore not responsible for any errors
or omissions in those reports. The recipients of these reports are responsible for determining whether the information contained therein is
sufficient for use and shall use their own skill and judgement when choosing to rely upon the reports

Associated Reports
Reports
Global Fish Processing Market
Global Aquaculture Market
Global Fish Sauce Market
Global Organic Food and Beverages Market
Global Goat Milk Market

T H A N K
Y O U
To know more about us, please visit our website:
www.prophecymarketinsights.com
For sales queries or new topics email us on:
sales@prophecymarketinsights.com
For other queries contact:
Alex L
(General Manager & Global Head - Business Development)
Prophecy Market Insights
101, Summer Street, Stamford, Connecticut - 01609
US.: + 1 860 531 2701
Email: sales@prophecymarketinsights.com

Aquaculture Vaccines Market is estimated to be US$ 946.5 million by 2032; Growing Prevalence of Fish Diseases in Aquaculture to Fuel Market Growth

Recommended

Recommended

More Related Content

Similar to Aquaculture Vaccines Market is estimated to be US$ 946.5 million by 2032; Growing Prevalence of Fish Diseases in Aquaculture to Fuel Market Growth

Similar to Aquaculture Vaccines Market is estimated to be US$ 946.5 million by 2032; Growing Prevalence of Fish Diseases in Aquaculture to Fuel Market Growth (12)

More from ankitakalvankar

More from ankitakalvankar (16)

Recently uploaded

Recently uploaded (20)

Aquaculture Vaccines Market is estimated to be US$ 946.5 million by 2032; Growing Prevalence of Fish Diseases in Aquaculture to Fuel Market Growth